Page last updated: 2024-09-04

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and cysteamine

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with cysteamine in 1 studies

Compound Research Comparison

Studies
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
Trials
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
Recent Studies (post-2010)
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
Studies
(cysteamine)
Trials
(cysteamine)
Recent Studies (post-2010) (cysteamine)
690423,30760666

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avenoso, A; Calatroni, A; Campo, GM; Campo, S; D'Ascola, A; Micali, A; Nastasi, G; Pisani, A; Puzzolo, D; Scuruchi, M1

Other Studies

1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and cysteamine

ArticleYear
The SOD mimic MnTM-2-PyP(5+) reduces hyaluronan degradation-induced inflammation in mouse articular chondrocytes stimulated with Fe (II) plus ascorbate.
    The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:8

    Topics: Animals; Ascorbic Acid; Cartilage, Articular; Chondrocytes; Cysteamine; Gene Expression Regulation; Hyaluronan Receptors; Hyaluronic Acid; Inflammation; Interleukin-1beta; Iron; Lipid Peroxidation; Male; Matrix Metalloproteinase 13; Metalloporphyrins; Mice; Molecular Weight; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Peptides; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2013
chemdatabank.com